Ischemic stroke is a serious clinical problem [@bb0030], [@bb0010]. To prevent ischemic stroke, it is crucial to identify clinical targets. Left atrial thrombus is a known cause of ischemic stroke [@bb0010], [@bb0015]; however, the cause of left atrial thrombus remains unknown.

Pulmonary vein thrombosis (PVT) is thought to be rare; however, I have published several cases of PVT in elderly patients with chest pain using a 64-slice multidetector CT (64-MDCT) since 2012 [@bb0035], [@bb0025], [@bb0040], [@bb0045], [@bb0050], [@bb0055], [@bb0060]. In 2014, I reported that 61% (35 patients) of 57 elderly patients with chest pain had PVT, as assessed using 64-MDCT, which suggests that PVT is common in elderly patients with chest pain [@bb0055]. Although I have reported that a thrombus in the pulmonary vein extends into the left atrium [@bb0025], [@bb0040], [@bb0050], [@bb0055], the relationship between PVT and a left atrial thrombus remains unknown.

I reviewed the images of 64-MDCT scans obtained from 35 patients with PVT. Seventeen patients (49%) had a thrombus in the left atrium, which was extended from pulmonary vein thrombi, indicating that approximately half of patients with PVT had a left atrial thrombus. In addition, among the 22 patients without PVT, only three patients (14%) had a left atrial thrombus. These three patients may have a fine pulmonary vein thrombus, which could not be clearly visualized using 64-MDCT. Thus, there is a possibility that nearly all left atrial thrombi are extended from pulmonary vein thrombi. Nearly all left atrial thrombi may use pulmonary vein thrombi as a root, which may provide a strong structure in the thrombi. In addition, I reported that some of the thrombi were partially dissolved within three months following warfarin [@bb0035] and dabigatran [@bb0045], [@bb0050], [@bb0055] treatment, indicating that warfarin and dabigatran could prevent ischemic stroke by dissolving the pulmonary vein thrombus and the connected left atrial thrombus. However, not all thrombi were dissolved upon warfarin [@bb0025] and dabigatran [@bb0060] treatment, and thus, more efficient anti-coagulants are needed to prevent ischemic stroke.
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